Virax Historical Income Statement
| VRAX Stock | USD 2.01 0.07 3.61% |
Historical analysis of Virax Biolabs income statement accounts such as Tax Provision of 0.0, Depreciation And Amortization of 97.9 K, Interest Expense of 28.3 K or Selling General Administrative of 2.7 M can show how well Virax Biolabs Group performed in making a profits. Evaluating Virax Biolabs income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Virax Biolabs's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Virax Biolabs Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Virax Biolabs Group is a good buy for the upcoming year.
Virax |
About Virax Income Statement Analysis
Virax Biolabs Group Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Virax Biolabs shareholders. The income statement also shows Virax investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Virax Biolabs Income Statement Chart
Add Fundamental
Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Virax Biolabs Group. It is also known as Virax Biolabs overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Virax Biolabs Group operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Virax Biolabs Group is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Virax Biolabs' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Virax Biolabs Group current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virax Biolabs Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Virax Biolabs' Interest Expense is fairly stable compared to the past year. Total Revenue is likely to rise to about 164.2 K in 2024, whereas Net Interest Income is likely to drop (28.2 K) in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 15.4K | 15.5K | 26.9K | 28.3K | Depreciation And Amortization | 1.7M | 1.0 | 103.1K | 97.9K |
Virax Biolabs income statement Correlations
Click cells to compare fundamentals
Virax Biolabs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Virax Stock Analysis
When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.